Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 91 Carcinoma, Non-Small-Cell Lung 84 Neoplasms 48 Carcinoma, Renal Cell 44 Neoplasm Metastasis 41 Squamous Cell Carcinoma of Head and Neck 36 Carcinoma, Hepatocellular 36 Colorectal Neoplasms 31 Pancreatic Neoplasms 24 Lung Neoplasms 20 Stomach Neoplasms 19 Head and Neck Neoplasms 18 Carcinoma, Transitional Cell 17 Hodgkin Disease 16 Breast Neoplasms 16 Small Cell Lung Carcinoma 15 Ovarian Neoplasms 14 Urinary Bladder Neoplasms 13 Recurrence 13 Advanced Cancer 13 Glioblastoma 12 Brain Neoplasms 12 Lymphoma 11 Kidney Neoplasms 11 Glioma 11 Prostatic Neoplasms 10 Lymphoma, Non-Hodgkin 10 Uveal Melanoma 9 Triple Negative Breast Neoplasms 9 Sarcoma 9

Interventions

pembrolizumab 3 Ipilimumab 2 Blood Specimen Collection 2 spartalizumab 1 necitumumab 1 mirdametinib 1 leronlimab 1 apatinib 1 Watchful Waiting 1 Tomography, X-Ray Computed 1 Therapeutics 1 Surveys and Questionnaires 1 Rosuvastatin Calcium 1 Radiotherapy 1 Radiation 1 Positron-Emission Tomography 1 PankoMab-GEX 1 Panitumumab 1 Nivolumab 1 Metformin 1 Magnetic Resonance Imaging 1 MEK inhibitor I 1 Jupiter 1 JPT1 protein, human 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 GAT 1 Fluorodeoxyglucose F18 1 FCN-437c 1 EBI-005 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor, Adult × Nivolumab × Clear all

NCT03728179 2024-02-20

RACIN

Centre Hospitalier Universitaire Vaudois

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡